M. Fuertes

588 total citations
6 papers, 86 citations indexed

About

M. Fuertes is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, M. Fuertes has authored 6 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in M. Fuertes's work include Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Bone and Joint Diseases (2 papers). M. Fuertes is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Bone and Joint Diseases (2 papers). M. Fuertes collaborates with scholars based in Spain, Mexico and Italy. M. Fuertes's co-authors include Jesús María Hernández‐Rivas, Rocío Benito, María Díez‐Campelo, Fernando Ramos, Carmen Chillón, Jesús F. San Miguel, Miguel Alcoceba, Alberto Órfão, Ramón García‐Sánz and Consuelo del Cañizo and has published in prestigious journals such as Blood, British Journal of Haematology and Oncotarget.

In The Last Decade

M. Fuertes

6 papers receiving 85 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Fuertes Spain	4	52	45	33	12	9	6	86
Elżbieta Patkowska Poland	7	90 1.7×	44 1.0×	36 1.1×	17 1.4×	7 0.8×	22	114
Hanna Janke Germany	3	127 2.4×	69 1.5×	48 1.5×	9 0.8×	4 0.4×	4	136
Taralynn Mack United States	4	74 1.4×	22 0.5×	54 1.6×	7 0.6×	5 0.6×	9	104
J.-Th. Fischer Germany	5	72 1.4×	52 1.2×	17 0.5×	28 2.3×	8 0.9×	9	101
Aimee Jackson United Kingdom	5	41 0.8×	22 0.5×	31 0.9×	17 1.4×	2 0.2×	14	85
Joshua S. Weinstock United States	4	54 1.0×	29 0.6×	36 1.1×	7 0.6×	2 0.2×	5	105
Kamaraj Karunanithi United Kingdom	5	36 0.7×	50 1.1×	40 1.2×	24 2.0×	5 0.6×	12	84
Stefano Ulisciani Italy	4	71 1.4×	40 0.9×	45 1.4×	10 0.8×		6	96
Ghayas C. Issa United States	6	132 2.5×	92 2.0×	28 0.8×	14 1.2×	3 0.3×	27	156
Lenny Straszkowski Australia	4	33 0.6×	22 0.5×	17 0.5×	18 1.5×	8 0.9×	8	66

Countries citing papers authored by M. Fuertes

Since Specialization

Citations

This map shows the geographic impact of M. Fuertes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fuertes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fuertes more than expected).

Fields of papers citing papers by M. Fuertes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fuertes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fuertes. The network helps show where M. Fuertes may publish in the future.

Co-authorship network of co-authors of M. Fuertes

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fuertes. A scholar is included among the top collaborators of M. Fuertes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fuertes. M. Fuertes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Fuertes, M., et al.. (2016). All-trans retinoic acid-induced myositis during treatment of acute promyelocytic leukemia. 3(2). 1 indexed citations

2.

Ramos, Fernando, Cristina Robledo, Dimas Suárez‐Vilela, et al.. (2016). Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis. Oncotarget. 7(21). 30492–30503. 38 indexed citations

3.

Abáigar, María, Fernando Ramos, Rocío Benito, et al.. (2013). Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. Annals of Hematology. 92(11). 1543–1552. 14 indexed citations

4.

Abáigar, María, Fernando Ramos, Rocío Benito, et al.. (2012). Prognostic Impact of the Number of Methylated Genes in Myelodysplastic Syndromes and Acute Myeloid Leukemias Treated with 5-Azacytidine. Blood. 120(21). 1717–1717. 1 indexed citations

5.

Sarasquete, María Eugenia, Ramón García‐Sánz, Carmen Chillón, et al.. (2008). Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma. British Journal of Haematology. 141(2). 212–215. 28 indexed citations

6.

Sarasquete, María Eugenia, Ramón García‐Sánz, M. Fuertes, et al.. (2006). The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma.. PubMed. 91(11). 1551–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact